Follow
Prof. Dr. Martin Pruschy
Prof. Dr. Martin Pruschy
Dept. Radiation Oncology; University Hospital Zurich
Verified email at usz.ch
Title
Cited by
Cited by
Year
Lateral clustering of the adhesive ectodomain: a fundamental determinant of cadherin function
WM Brieher, M Pruschy, BM Gumbiner
Current Biology 7 (5), 308-315, 1997
4581997
Radiotherapy promotes tumor-specific effector CD8+ T cells via dendritic cell activation
A Gupta, HC Probst, V Vuong, A Landshammer, S Muth, H Yagita, ...
The Journal of Immunology 189 (2), 558-566, 2012
4402012
PKC412-a protein kinase inhibitor with a broad therapeutic potential
D Fabbro, S Ruetz, S Bodis, M Pruschy, K Csermak, A Man, ...
Anti-cancer drug design 15 (1), 17-28, 2000
3792000
Ceramide induces cytochrome c release from isolated mitochondria: importance of mitochondrial redox state
P Ghafourifar, SD Klein, O Schucht, U Schenk, M Pruschy, S Rocha, ...
Journal of biological chemistry 274 (10), 6080-6084, 1999
3291999
Glucose and palmitic acid induce degeneration of myofibrils and modulate apoptosis in rat adult cardiomyocytes
D Dyntar, M Eppenberger-Eberhardt, K Maedler, M Pruschy, ...
Diabetes 50 (9), 2105-2113, 2001
2752001
Effect of VEGF receptor inhibitor PTK787/ZK222548 combined with ionizing radiation on endothelial cells and tumour growth
C Hess, V Vuong, I Hegyi, O Riesterer, J Wood, D Fabbro, C Glanzmann, ...
British journal of cancer 85 (12), 2010-2016, 2001
2202001
Primary structure of the cAMP-dependent phosphorylation site of the plasma membrane calcium pump
PH James, M Pruschy, TE Vorherr, JT Penniston, E Carafoli
Biochemistry 28 (10), 4253-4258, 1989
1811989
Apoptosis-modulating agents in combination with radiotherapy—current status and outlook
C Belka, V Jendrossek, M Pruschy, S Vink, M Verheij, W Budach
International Journal of Radiation Oncology* Biology* Physics 58 (2), 542-554, 2004
1752004
Tumor recovery by angiogenic switch from sprouting to intussusceptive angiogenesis after treatment with PTK787/ZK222584 or ionizing radiation
R Hlushchuk, O Riesterer, O Baum, J Wood, G Gruber, M Pruschy, ...
The American journal of pathology 173 (4), 1173-1185, 2008
1722008
Complement is a central mediator of radiotherapy-induced tumor-specific immunity and clinical response
L Surace, V Lysenko, AO Fontana, V Cecconi, H Janssen, A Bicvic, ...
Immunity 42 (4), 767-777, 2015
1662015
Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin
Y Shi, E Felley-Bosco, TM Marti, K Orlowski, M Pruschy, RA Stahel
BMC cancer 12, 1-10, 2012
1352012
Differential DNA repair pathway choice in cancer cells after proton-and photon-irradiation
AO Fontana, MA Augsburger, N Grosse, M Guckenberger, AJ Lomax, ...
Radiotherapy and Oncology 116 (3), 374-380, 2015
1212015
Deficiency in homologous recombination renders mammalian cells more sensitive to proton versus photon irradiation
N Grosse, AO Fontana, EB Hug, A Lomax, A Coray, M Augsburger, ...
International Journal of Radiation Oncology* Biology* Physics 88 (1), 175-181, 2014
1202014
Post-radiochemotherapy PET radiomics in head and neck cancer–the influence of radiomics implementation on the reproducibility of local control tumor models
M Bogowicz, RTH Leijenaar, S Tanadini-Lang, O Riesterer, M Pruschy, ...
Radiotherapy and Oncology 125 (3), 385-391, 2017
1012017
The phosphatidylinositide 3′-kinase/Akt survival pathway is a target for the anticancer and radiosensitizing agent PKC412, an inhibitor of protein kinase C
A Tenzer, D Zingg, S Rocha, B Hemmings, D Fabbro, C Glanzmann, ...
Cancer research 61 (22), 8203-8210, 2001
962001
Degradation of PKB/Akt protein by inhibition of the VEGF receptor/mTOR pathway in endothelial cells
O Riesterer, D Zingg, J Hummerjohann, S Bodis, M Pruschy
Oncogene 23 (26), 4624-4635, 2004
942004
Potentiation of DNA-damage-induced cytotoxicity by G2checkpoint abrogators
A Tenzer, M Pruschy
Current medicinal chemistry-anti-cancer agents 3 (1), 35-46, 2003
932003
MVP and vaults: a role in the radiation response
PC Lara, M Pruschy, M Zimmermann, LA Henríquez-Hernández
Radiation Oncology 6, 1-9, 2011
922011
Recombinant mistletoe lectin induces p53-independent apoptosis in tumour cells and cooperates with ionising radiation
K Hostanska, V Vuong, S Rocha, MS Soengas, C Glanzmann, R Saller, ...
British journal of cancer 88 (11), 1785-1792, 2003
912003
NKG2D-dependent antitumor effects of chemotherapy and radiotherapy against glioblastoma
T Weiss, H Schneider, M Silginer, A Steinle, M Pruschy, B Polić, M Weller, ...
Clinical Cancer Research 24 (4), 882-895, 2018
902018
The system can't perform the operation now. Try again later.
Articles 1–20